Jiangsu

  • Jiangsu Yanshen Suspends Production

    Simcere Pharmaceutical Group has reported that its subsidiary Jiangsu Yanshen Biological Technology Stock Co has suspended the production of all its products in order to conduct an internal inspection and improve its quality control systems. Jinsh…

    Jiangsu | 20 January 2010

  • Bayer AG Acquires Jiangsu Qidong Gaitianli

    German-based Bayer AG has announced that it will acquire 54.5 percent of Jiangsu Qidong Gaitianli Medicines Co., Ltd. The acquisition is worth a total of US$163.8 million. The second largest European drug maker will acquire four of Jiangsu Qidong…

    Jiangsu | 30 May 2006